You are here
Pfizer requests emergency authorization for its oral antiviral COVID-19 treatment
Primary tabs
Tue, 2021-11-16 17:51 — mike kraft
Pfizer requests emergency authorization for antiviral COVID-19 Pfizer requested emergency authorization for its antiviral oral COVID-19 treatment on Tuesday after a study found the pills dramatically reduced the risk of hospitalization. TheHill
The pharmaceutical giant is asking the Food and Drug Administration (FDA) to grant authorization for Paxlovid to treat mild to moderate COVID-19 in patients at a higher risk of hospitalization and death.
Pfizer’s request makes Paxlovid the second oral COVID-19 treatment that the FDA is considering for an emergency use authorization. Merck and its partner Ridgeback Biotherapeutics submitted for authorization of molnupiravir last month. ...
Country / Region Tags:
Problem, Solution, SitRep, or ?:
Groups this Group Post belongs to:
- Private group -
Recent Comments